404 related articles for article (PubMed ID: 17327450)
1. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
[TBL] [Abstract][Full Text] [Related]
2. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
[TBL] [Abstract][Full Text] [Related]
3. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.
Jiang C; Kim JH; Li F; Qu A; Gavrilova O; Shah YM; Gonzalez FJ
J Biol Chem; 2013 Feb; 288(6):3844-57. PubMed ID: 23255598
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes.
Kudoh A; Satoh H; Hirai H; Watanabe T
Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306
[TBL] [Abstract][Full Text] [Related]
6. Long-term interleukin-1alpha treatment inhibits insulin signaling via IL-6 production and SOCS3 expression in 3T3-L1 adipocytes.
Uno T; He J; Usui I; Kanatani Y; Bukhari A; Fujisaka S; Yamazaki Y; Suzuki H; Iwata M; Ishiki M; Urakaze M; Haruta T; Ogawa H; Kobayashi M
Horm Metab Res; 2008 Jan; 40(1):8-12. PubMed ID: 18085494
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice.
Aoyama T; Ikejima K; Kon K; Okumura K; Arai K; Watanabe S
Hepatology; 2009 May; 49(5):1636-44. PubMed ID: 19205029
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.
Collino M; Aragno M; Castiglia S; Miglio G; Tomasinelli C; Boccuzzi G; Thiemermann C; Fantozzi R
Br J Pharmacol; 2010 Aug; 160(8):1892-902. PubMed ID: 20233219
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte.
Liu Z; Gan L; Zhou Z; Jin W; Sun C
Immunobiology; 2015 Aug; 220(8):947-53. PubMed ID: 25720636
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
14. Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice.
Sharma M; Mohapatra J; Malik U; Nagar J; Chatterjee A; Ramachandran B; Jain MR
J Diabetes; 2017 Jun; 9(6):613-621. PubMed ID: 27530729
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor α and suppressor of cytokine signaling 3.
Jiang Y; Thakran S; Bheemreddy R; Ye EA; He H; Walker RJ; Steinle JJ
J Biol Chem; 2014 Sep; 289(38):26395-26405. PubMed ID: 25086044
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
[TBL] [Abstract][Full Text] [Related]
17. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
Lv Q; Wang Y; Wang W; Wang L; Zhou X
Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase.
Pereira RI; Leitner JW; Erickson C; Draznin B
Life Sci; 2008 Nov; 83(19-20):638-43. PubMed ID: 18824177
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
[TBL] [Abstract][Full Text] [Related]
20. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
